190 related articles for article (PubMed ID: 10822381)
1. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers.
Yanagisawa K; Uchida K; Nagatake M; Masuda A; Sugiyama M; Saito T; Yamaki K; Takahashi T; Osada H
Oncogene; 2000 May; 19(19):2305-11. PubMed ID: 10822381
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
3. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
Stroschein SL; Wang W; Luo K
J Biol Chem; 1999 Apr; 274(14):9431-41. PubMed ID: 10092624
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
7. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
8. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.
Feng XH; Zhang Y; Wu RY; Derynck R
Genes Dev; 1998 Jul; 12(14):2153-63. PubMed ID: 9679060
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy.
Dong C; Zhu S; Wang T; Yoon W; Goldschmidt-Clermont PJ
J Heart Lung Transplant; 2002 Sep; 21(9):999-1008. PubMed ID: 12231371
[TBL] [Abstract][Full Text] [Related]
12. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
13. Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4.
Morén A; Itoh S; Moustakas A; Dijke P; Heldin CH
Oncogene; 2000 Sep; 19(38):4396-404. PubMed ID: 10980615
[TBL] [Abstract][Full Text] [Related]
14. Intracellular signaling of the TGF-beta superfamily by Smad proteins.
Kawabata M; Imamura T; Inoue H; Hanai J; Nishihara A; Hanyu A; Takase M; Ishidou Y; Udagawa Y; Oeda E; Goto D; Yagi K; Kato M; Miyazono K
Ann N Y Acad Sci; 1999; 886():73-82. PubMed ID: 10667205
[TBL] [Abstract][Full Text] [Related]
15. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
[TBL] [Abstract][Full Text] [Related]
16. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator.
Shioda T; Lechleider RJ; Dunwoodie SL; Li H; Yahata T; de Caestecker MP; Fenner MH; Roberts AB; Isselbacher KJ
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9785-90. PubMed ID: 9707553
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
Pierreux CE; Nicolás FJ; Hill CS
Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
[TBL] [Abstract][Full Text] [Related]
20. Dominant-negative Smad2 mutants inhibit activin/Vg1 signaling and disrupt axis formation in Xenopus.
Hoodless PA; Tsukazaki T; Nishimatsu S; Attisano L; Wrana JL; Thomsen GH
Dev Biol; 1999 Mar; 207(2):364-79. PubMed ID: 10068469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
